Ligand profile
IVH
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03557 — DNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
IVH- PDB
3pn1- UniProt (similar protein)
P43813- Target protein
- KP13_03557
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 139.5
- −1 ≤ LogP ≤ 5 -0.09
- MW ≤ 500 Da 355.4
- LogP ≤ 5 -0.09
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 10
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 139.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCSc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NCCCCSc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
InChI=1S/C14H21N5O4S/c1-2-3-4-24-14-17-11(15)8-12(18-14)19(6-16-8)13-10(22)9(21)7(5-20)23-13/h6-7,9-10,13,20-22H,2-5H2,1H3,(H2,15,17,18)/t7-,9-,10-,13-/m1/s1InChI=1S/C14H21N5O4S/c1-2-3-4-24-14-17-11(15)8-12(18-14)19(6-16-8)13-10(22)9(21)7(5-20)23-13/h6-7,9-10,13,20-22H,2-5H2,1H3,(H2,15,17,18)/t7-,9-,10-,13-/m1/s1
JUZWTKSKLZRPBL-QYVSTXNMSA-NJUZWTKSKLZRPBL-QYVSTXNMSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01653
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand IVH →
- PDB RCSB structure 3pn1 →
- UniProt UniProt P43813 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “IVH”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03557.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).